Get the Stockscreener App
57.51
0.86%
0.49
After Hours:
57.61
0.10
+0.17%
State Street Spdr S P Pharmaceuticals Etf stock is traded at $57.51, with a volume of 38,387.
It is up +0.86% in the last 24 hours and up +0.74% over the past month.
See More
Previous Close:
$57.02
Open:
$57.22
24h Volume:
38,387
Relative Volume:
0.53
Market Cap:
$229.97M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+2.64%
1M Performance:
+0.74%
6M Performance:
+35.29%
1Y Performance:
+29.24%
1-Day Range:
$57.09
$58.00
1-Week Range:
$54.80
$58.00
52-Week Range:
$35.22
$58.00
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Company Profile
Name
State Street Spdr S P Pharmaceuticals Etf
Sector
Industry
Phone
-
Address
-
Compare XPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XPH
State Street Spdr S P Pharmaceuticals Etf
|
57.51 | 229.97M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
340.87 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
688.98 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
691.96 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
277.66 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
620.76 | 124.43B | 0 | 0 | 0 | 0.00 |
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Latest News
BBH: Mature Biotech Exposure, But Limited Growth Ahead (NASDAQ:BBH) - Seeking Alpha
5 Biggest Pharmaceutical ETFs for Investors in 2026 - Nasdaq
Winners & Losers: The ETF Playbook to Glide Trump's Great Healthcare Plan - sharewise.com
XPH: Healthcare Dashboard For January (NYSEARCA:XPH) - Seeking Alpha
Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks' - Benzinga
5 Biggest Clean Energy ETFs in 2026 - Investing News Network
Here's What to Expect From Vertex Pharmaceuticals' Next Earnings Report - FinancialContent
Should You Invest in the State Street SPDR S&P Semiconductor ETF (XSD)? - Yahoo Finance
ValuEngine Weekly Market Summary And Commentary - Seeking Alpha
01/12/2026 ValuEngine Weekly Market Summary & Commentary - The Globe and Mail
‘Biotech Super Bowl’ Lands With a Thud. Stocks Slide on Lack of Deal News. - Barron's
Is State Street SPDR S&P Telecom ETF (XTL) a Strong ETF Right Now? - Yahoo Finance
Better Small-Cap Growth ETF: Vanguard's VBK vs. State Street's SLYG - The Globe and Mail
Here's Why Biotech ETFs Are Rallying Hard - Yahoo Finance
Should You Invest in the State Street SPDR S&P Transportation ETF (XTN)? - Yahoo Finance
State Street SPDR S&P Pharmaceuticals ETF (NY: XPH - FinancialContent
5 ETFs to Buy for January - Yahoo Finance
Is State Street SPDR S&P Bank ETF (KBE) a Strong ETF Right Now? - Yahoo Finance
The Best S&P 500 ETF to Invest $5,000 in as 2026 Begins - The Motley Fool
As Artificial Intelligence Stocks Surge in Value, Health Care ETFs Take Center Stage for Growth - Bitget
As AI Valuations Stretch, Health Care ETFs Step Into The Growth Spotlight - Benzinga
Should You Invest in the State Street SPDR S&P Bank ETF (KBE)? - Yahoo Finance
Should You Invest in the State Street SPDR S&P Retail ETF (XRT)? - Yahoo Finance
Biotech and pharma stocks tumble as investors race into energy - MSN
Biotech and Pharma Stocks Tumble as Investors Race into Energy - Barron's
Should You Invest in the State Street SPDR S&P Insurance ETF (KIE)? - Yahoo Finance
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now? - MSN
Is State Street SPDR S&P Oil & Gas Exploration & Production ETF (XOP) a Strong ETF Right Now? - Yahoo Finance
Is State Street SPDR S&P Homebuilders ETF (XHB) a strong ETF right now? - MSN
The Year-End 2025 Biotech Rally And What It Means For 2026 - Benzinga
Is State Street SPDR S&P Homebuilders ETF (XHB) a Strong ETF Right Now? - Yahoo Finance
Chart of the Week: Moderna Stock May Be Finding a Bottom - Barron's
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)? - MSN
Is State Street SPDR S&P Oil & Gas Equipment & Services ETF (XES) a Strong ETF Right Now? - Yahoo Finance
SPDR Series TrustState Street SPDR S&P Pharmaceuticals ETF announces Quarterly dividend, payable on December 24, 2025 - MarketScreener
Is State Street SPDR S&P Software & Services ETF (XSW) a Strong ETF Right Now? - Yahoo Finance
Should You Invest in the State Street SPDR S&P Homebuilders ETF (XHB)? - Nasdaq
Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus - Sahm
Bet on These Top-Ranked Healthcare ETFs Before 2025 Ends - The Globe and Mail
Should You Invest in the State Street SPDR S&P Oil & Gas Equipment & Services ETF (XES)? - Yahoo Finance
XPH Stock Institutional Owners - Quiver Quantitative
Why Health Care ETFs Aren't Panicking Over Big Pharma's Price Cuts - Benzinga
Should State Street SPDR Portfolio S&P 600 Small Cap ETF (SPSM) Be on Your Investing Radar? - Yahoo Finance
Should You Invest in the State Street SPDR S&P Aerospace & Defense ETF (XAR)? - Yahoo Finance
Should You Invest in the State Street Health Care Select Sector SPDR ETF ETF (XLV)? - MSN
6 Top-Performing ETF Areas of Last Week - TradingView — Track All Markets
Should You Invest in the State Street SPDR S&P Biotech ETF (XBI)? - Yahoo Finance
Is State Street SPDR Portfolio S&P 500 High Dividend ETF (SPYD) a Strong ETF Right Now? - Yahoo Finance
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Financials Data
There is no financial data for State Street Spdr S P Pharmaceuticals Etf (XPH). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):